Suchen und finden Sie den CMO / CDMO, den Sie brauchen
Discover highly skilled partners for your drug development and manufacturing project.
Showing 11 facilities
…
Vereinigtes Königreich
Upperton Pharma Solutions
Upperton Pharma Solutions
Entwicklung und Herstellung oraler fester Dosen (OSD), nasaler, inhalativer und steriler Trockenpulver und flüssiger Arzneimittel.
BATCH-GRÖSSE: Klein, Mittel
THERAPEUTISCHE FACHGEBIETE (ATC): (R) Respiratory system, (C) Cardiovascular system, (N) Nervous system
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS, SERVICES, OLIGONUKLEOTIDE, BIOLOGIEN
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGION: Europe
VERWENDUNG: Menschlich
COMPLIANCE: MHRA (UK GMP)
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
MÄRKTE: FDA (USA), EMA (EU), TGA (Australia), Health Canada (Canada), MHRA (UK)
BSL (Biologische Sicherheitsstufe): 1
Vereinigtes Königreich
Pharmaron API Commercial Synthesis Cramlington (UK)
Pharmaron
Kommerzielle API-Synthese kleiner Moleküle.
BATCH-GRÖSSE: Klein, Mittel, Groß
THERAPEUTISCHE FACHGEBIETE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
COMPLIANCE: EMA (EU-GMP), PMDA/MHLW (Japan GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Gesundheit Kanada (Kanada GMP), MFDS/KFDA (Republik Korea GMP)
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGION: Europe
MÄRKTE: ANVISA (Brazil), PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)
VERWENDUNG: Menschlich, Veterinär
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
KATEGORIE/PRODUKT: CHEMICAL-SYNTHETIC
Vereinigtes Königreich
CARBOGEN AMCIS | Manchester, UK
CARBOGEN AMCIS
Entdecken Sie unsere Kapazitäten zur Herstellung kosmetischer Inhaltsstoffe, Feinchemikalien und kundenspezifischer Synthese von Pharmazwischenprodukten.
BATCH-GRÖSSE: Klein, Mittel, Groß
KATEGORIE/PRODUKT: SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
REGION: Europe
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Development services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
COMPLIANCE: ECOVADIS, ISO, Halal-Forschungsrat
Vereinigtes Königreich
Seda Pharma Development Services
Seda Pharma Development Services Ltd
Seda Pharmaceutical Development Services ist auf integrierte pharmazeutische Entwicklung und klinische Pharmakologie spezialisiert.
MÄRKTE: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
BATCH-GRÖSSE: Klein, Mittel
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS
REGION: Europe
VERWENDUNG: Menschlich
COMPLIANCE: MHRA (UK GMP), ECOVADIS
DIENSTLEISTUNGEN: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag)
THERAPEUTISCHE FACHGEBIETE (ATC): (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs
Limited view
SERVICES manufacturing site
MAI network supplier
F&E- und GMP-Produktionsstandort, Bowburn, Durham, Großbritannien
Location available after registration
Limited view
SERVICES manufacturing site
MAI network supplier
Forschungs- und Entwicklungszentrum
Location available after registration
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Flüssige und lyophilisierte Fläschchen – Zwei Annex-I-konforme BSL-2-Reinraumsuiten.
Location available after registration
Suggested Results
These facilities match your main criteria but not all optional filters.
Spanien
Laboratorio REIG JOFRE, SA (TOLEDO PLANT)
LABORATORIO REIG JOFRE SA
Entwicklung und Herstellung von Betalactam-Antibiotika (FDF) in hochmodernen Anlagen.
MÄRKTE: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)
REGION: APAC, MENA, LATAM, Europe, North America
COMPLIANCE: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU-GMP), Gesundheit Kanada (Kanada GMP), Weltgesundheitsorganisation (GMP / HACCP), MHRA (UK GMP)
BATCH-GRÖSSE: Groß, Mittel
VERWENDUNG: Menschlich, Veterinär
BSL (Biologische Sicherheitsstufe): 1
DIENSTLEISTUNGEN: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
THERAPEUTISCHE FACHGEBIETE (ATC): (J) Antiinfectives for systemic use
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS
Spanien
Laboratorios Grifols | Barcelona Plant
Grifols International
Sterile Herstellungslösungen (kleine Moleküle) in flexiblen Beuteln und Fläschchen.
MÄRKTE: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)
DIENSTLEISTUNGEN: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
REGION: Europe
COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentinien neue GMP), EMA (EU-GMP), Gesundheit Kanada (Kanada GMP), Weltgesundheitsorganisation (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republik Korea GMP)
BATCH-GRÖSSE: Groß, Klein, Mittel
VERWENDUNG: Menschlich, Veterinär
THERAPEUTISCHE FACHGEBIETE (ATC): (C) Cardiovascular system, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day)
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS
Belgien
White Raven - Legiapark
White Raven
Abfüll- und Endbearbeitungsstandort für die GMP-Formulierung und die aseptische Abfüllung steriler flüssiger Injektionspräparate.
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/Tag), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day)
MÄRKTE: EMA (EU)
REGION: Europe
VERWENDUNG: Menschlich
BSL (Biologische Sicherheitsstufe): 1, 2
DIENSTLEISTUNGEN: Manufacturing services, Packaging
BATCH-GRÖSSE: Klein, Mittel
COMPLIANCE: EMA (EU-GMP)
KATEGORIE/PRODUKT: BIOLOGIEN, FDF / DRUG PRODUCTS
Spanien
Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
LABORATORIO REIG JOFRE SA
Produktionsanlagen für injizierbare (Lyo und Flüssigkeiten) und Flüssigkeiten.
BSL (Biologische Sicherheitsstufe): 3, 1, 2
MÄRKTE: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)
REGION: Europe
BATCH-GRÖSSE: Groß, Mittel
VERWENDUNG: Menschlich, Veterinär
DIENSTLEISTUNGEN: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
THERAPEUTISCHE FACHGEBIETE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism
KONTROLLIERTE SUBSTANZEN: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
COMPLIANCE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU-GMP), Gesundheit Kanada (Kanada GMP), Weltgesundheitsorganisation (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republik Korea GMP)
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day)
KATEGORIE/PRODUKT: FDF / DRUG PRODUCTS
COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (EU-GMP), Weltgesundheitsorganisation (GMP / HACCP)
MÄRKTE: EMA (EU), FDA (USA)
REGION: Europe
BATCH-GRÖSSE: Groß, Klein, Mittel
VERWENDUNG: Menschlich, Veterinär
KATEGORIE/PRODUKT: OLIGONUKLEOTIDE
DIENSTLEISTUNGEN: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/Tag), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/Tag), 1 / low-hazard (PDE > 10,000 µg/day)
More facilities on the network
Register to unlock the full catalog with contact details and locations.
+4 more facilities
Create free account